Cargando…

A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years

OBJECTIVE: We performed a randomised trial in very preterm, small for gestational age (SGA) babies to determine if prophylaxis with granulocyte macrophage colony stimulating factor (GM-CSF) improves outcomes (the PROGRAMS trial). GM-CSF was associated with improved neonatal neutrophil counts, but no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marlow, Neil, Morris, Timothy, Brocklehurst, Peter, Carr, Robert, Cowan, Frances, Patel, Nishma, Petrou, Stavros, Redshaw, Margaret, Modi, Neena, Doré, Caroline J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484494/ https://www.ncbi.nlm.nih.gov/pubmed/25922190 http://dx.doi.org/10.1136/archdischild-2014-307410

Ejemplares similares

A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years
por: Marlow, Neil, et al.
Publicado: (2013)

Cost effectiveness of alternative planned places of birth in woman at low risk of complications: evidence from the Birthplace in England national prospective cohort study
por: Schroeder, Elizabeth, et al.
Publicado: (2012)

Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
por: Mu, Xiuying, et al.
Publicado: (2021)

Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011)

Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock
por: Schefold, Joerg C
Publicado: (2011)

Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis
por: Krebs, Jörg, et al.
Publicado: (2019)

Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis
por: Alp, Emine, et al.
Publicado: (2004)

Granulocyte Colony-stimulating Factor for Preterms with Sepsis and Neutropenia: A Randomized Controlled Trial
por: Chaudhuri, Jasodhara, et al.
Publicado: (2012)

Granulocyte colony‐stimulating factor is not pathogenic in lupus nephritis
por: Gottschalk, Timothy A., et al.
Publicado: (2021)

Thrombin Stimulates Synthesis of Macrophage Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor by Human Proximal Tubular Epithelial Cells in Culture
por: Shimaya, Yuko, et al.
Publicado: (2012)

Granulocyte colony-stimulating factor and leukemogenesis.
por: de Figueiredo, Lorena Lobo, et al.
Publicado: (2004)

Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by Granulocyte-/Granulocyte-macrophage colony stimulating factors
por: Bali, Kiran Kumar, et al.
Publicado: (2013)

CD64 upregulation on peripheral granulocytes is not a marker of sepsis and does not correlate with serum concentrations of granulocyte colony-stimulating factor (G-CSF) in postoperative/posttraumatic patients with severe sepsis
por: Weiss, M, et al.
Publicado: (1998)

Enhancement of Cytosine Arabinoside Cytotoxicity by Granulocyte/Macrophage Colony‐stimulating Factor and Granulocyte Colony‐stimulating Factor in a Human Myeloblastic Leukemia Cell Line
por: Takauji, Rumiko, et al.
Publicado: (1993)

Granulocyte, granulocyte–macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells
por: Pei, X-H, et al.
Publicado: (1999)

Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis
por: Sehgal, Rashi, et al.
Publicado: (2022)

Granulocyte Colony-Stimulating Factor in Amniotic Fluid
por: Raynor, B. Denise, et al.
Publicado: (1995)

The importance of the granulocyte-colony stimulating factor in oncology
por: CETEAN, SÎNZIANA, et al.
Publicado: (2015)

Granulocyte Colony-stimulating Factor-associated Aortitis
por: Nishioka, Hiroaki, et al.
Publicado: (2023)

A methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based economic evaluations
por: Achana, Felix, et al.
Publicado: (2017)

Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
por: Kaufman, Howard L, et al.
Publicado: (2014)

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)

Granulocyte‐macrophage colony‐stimulating factor: Conductor of the wound healing orchestra?
por: Ead, J. Karim, et al.
Publicado: (2023)

In vitro Colony Forming Cells and Colony Stimulating Factor in Chronic Granulocytic Leukaemia
por: Goldman, J. M., et al.
Publicado: (1974)

Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats
por: Papalois, Apostolos E., et al.
Publicado: (2019)

Granulocyte-colony stimulating factor producing rectal cancer
por: Takahashi, Hiroki, et al.
Publicado: (2008)

Serum Granulocyte Colony-Stimulating Factor and Alzheimer's Disease
por: Barber, Robert C., et al.
Publicado: (2012)

Role of granulocyte colony-stimulating factor in human reproduction
por: Eftekhar, Maryam, et al.
Publicado: (2018)

Migratory Aortitis Associated with Granulocyte-colony-stimulating Factor
por: Shirai, Tsuyoshi, et al.
Publicado: (2020)

Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
por: Morinaga, Ryota, et al.
Publicado: (2019)

Granulocyte colony‐stimulating factor producing retroperitoneal leiomyosarcoma
por: Fukuta, Kyotaro, et al.
Publicado: (2020)

Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor
Publicado: (1986)

Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection
por: Brown, Pierre Antoine, et al.
Publicado: (2005)

The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions
por: Krieger, Markus, et al.
Publicado: (2012)

Acute lung injury following the use of granulocyte-macrophage colony-stimulating factor
por: Kudlak, Kristina, et al.
Publicado: (2013)

Granulocyte-Macrophage Colony-Stimulating Factor Production and Tissue Eosinophilia in Chronic Rhinitis
por: Peric, Aleksandar, et al.
Publicado: (2016)

Role of granulocyte macrophage colony stimulating factor in regeneration of the central nervous system
por: Shanmugalingam, Ushananthini, et al.
Publicado: (2016)

Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
por: Aram, Jehan, et al.
Publicado: (2018)

The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis
por: Monaghan, Kelly L., et al.
Publicado: (2020)

The Effect of Granulocyte Colony Stimulating Factor Administration on Preterm Infant with Neutropenia and Clinical Sepsis: A Randomized Clinical Trial
por: Borjianyazdi, L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nfkcm7soqhcvj59sin6cp5crkh